Your session is about to expire
← Back to Search
Other
Vaporous Hyperoxia Therapy for Foot Ulcer (VHTDFU2 Trial)
N/A
Waitlist Available
Led By Dustin Kruse, DPM
Research Sponsored by Vaporox
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 20 weeks
Awards & highlights
VHTDFU2 Trial Summary
This trial will test whether Vaporous Hyperoxia Therapy can help heal Diabetic Foot Ulcers.
Eligible Conditions
- Foot Ulcer
VHTDFU2 Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 20 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~20 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Wound closure rate at 20 weeks
Secondary outcome measures
Time to 50%, 75%, 100% wound closure
Wound closure rate at 12 weeks
VHTDFU2 Trial Design
1Treatment groups
Experimental Treatment
Group I: VHT treatmentExperimental Treatment1 Intervention
Patients will be treated with VHT for 55 minutes at a minimum frequency of 2 times per week
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Vaporous Hyperoxia Therapy
2005
N/A
~40
Find a Location
Who is running the clinical trial?
VaporoxLead Sponsor
1 Previous Clinical Trials
31 Total Patients Enrolled
1 Trials studying Foot Ulcer
31 Patients Enrolled for Foot Ulcer
Dustin Kruse, DPMPrincipal InvestigatorRocky Mountain Foot and Ankle Center
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger